Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Glycine levels

ERBB4 · rs934607

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−11, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 98,316 European ancestry individuals.

The effect Each copy of the G allele shifted the measure 0.00229 lower (95% confidence interval 0.0016-0.0029); p = 6 × 10−12.

How common The G allele had a frequency of about 39% in the people studied.

Where it sits Chromosome 2, band 2q34 — in an intron of ERBB4.

What ClinVar records

Classification Benign; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 3 submitters), last evaluated 2024-07-15. ClinVar record 1229651 NM_005235.3(ERBB4):c.3136-92C>T

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-10-19 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean KRGDB
A 76.4% · G 23.6%
Korean Korea4K
A 75.9% · G 24.1%
Korean Korea1K
A 75.0% · G 25.0%
Japanese ToMMo
A 78.7% · G 21.3%
Vietnamese
A 74.1% · G 25.9%
World gnomAD
A 63.6% · G 36.4%
World 1000 Genomes
A 68.1% · G 31.9%
World TOPMed
A 63.9% · G 36.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

A/A No copy of the version the research linked to Glycine levels. This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Glycine levels. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Glycine levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Glycine levels (rs934607). MyGeneLog™. https://www.mygenelog.com/variants/rs934607

← See all variants